CLDX
Price
$26.56
Change
+$0.12 (+0.45%)
Updated
Nov 26, 12:25 PM (EDT)
Capitalization
1.76B
96 days until earnings call
Intraday BUY SELL Signals
HOWL
Price
$0.97
Change
+$0.06 (+6.59%)
Updated
Nov 26, 10:31 AM (EDT)
Capitalization
44.19M
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLDX vs HOWL

Header iconCLDX vs HOWL Comparison
Open Charts CLDX vs HOWLBanner chart's image
Celldex Therapeutics
Price$26.56
Change+$0.12 (+0.45%)
Volume$100
Capitalization1.76B
Werewolf Therapeutics
Price$0.97
Change+$0.06 (+6.59%)
Volume$200
Capitalization44.19M
CLDX vs HOWL Comparison Chart in %
CLDX
Daily Signal:
Gain/Loss:
HOWL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLDX vs. HOWL commentary
Nov 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and HOWL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 26, 2025
Stock price -- (CLDX: $26.44 vs. HOWL: $0.91)
Brand notoriety: CLDX and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 43% vs. HOWL: 42%
Market capitalization -- CLDX: $1.76B vs. HOWL: $44.19M
CLDX [@Biotechnology] is valued at $1.76B. HOWL’s [@Biotechnology] market capitalization is $44.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLDX and HOWL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 6 TA indicator(s) are bullish while HOWL’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 6 bullish, 4 bearish.
  • HOWL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than HOWL.

Price Growth

CLDX (@Biotechnology) experienced а +3.36% price change this week, while HOWL (@Biotechnology) price change was -0.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.65%. For the same industry, the average monthly price growth was -2.10%, and the average quarterly price growth was +70.72%.

Reported Earning Dates

CLDX is expected to report earnings on Mar 02, 2026.

HOWL is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.76B) has a higher market cap than HOWL($44.2M). CLDX YTD gains are higher at: 4.630 vs. HOWL (-38.493). HOWL has higher annual earnings (EBITDA): -66.34M vs. CLDX (-231.4M). CLDX has more cash in the bank: 630M vs. HOWL (77.6M). CLDX has less debt than HOWL: CLDX (3.03M) vs HOWL (37.1M). CLDX has higher revenues than HOWL: CLDX (5.79M) vs HOWL (0).
CLDXHOWLCLDX / HOWL
Capitalization1.76B44.2M3,975%
EBITDA-231.4M-66.34M349%
Gain YTD4.630-38.493-12%
P/E RatioN/AN/A-
Revenue5.79M0-
Total Cash630M77.6M812%
Total Debt3.03M37.1M8%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXHOWL
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
78%
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signal:
Gain/Loss:
HOWL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACCO3.450.10
+2.99%
Acco Brands Corp
DBGI6.790.17
+2.57%
Digital Brands Group Inc
COLL45.600.02
+0.05%
Collegium Pharmaceutical
SFSHF8.80N/A
N/A
Safestore Holdings PLC
TRYIF6.57N/A
N/A
Toray Industries Inc.